US OptionsDetailed Quotes

ABT240705C98000

Watchlist

5.85
0.000.00%

15min DelayTrading Jun 28 15:31 ET

0.00High0.00Low

Abbott Laboratories Stock Discussion

Movers and Shakers

Apr 17 07:10

ColumnsToday's Morning Movers and Top Ratings: ASML, LLY, ADSK, UAL and More

Morning Movers
Gapping up
$United Airlines(UAL.US)$ stock rose 5.2% after the carrier forecast stronger-than-expected earnings in the current quarter and reported a narrower-than-expected loss in the first quarter, buoyed by robust demand for travel.
$Abbott Laboratories(ABT.US)$ stock increased by 1.6% after the company surpassed quarterly profit expectations and raised the lower end of its earnings forecast, with strong dem...

What's your options trading tales?

Senorita Earnings

Apr 16 05:59

ColumnsPreview of Abbott's Q1 performance: The COVID-19 pandemic dividend dissipates, and cost pressures increase

$Abbott Laboratories(ABT.US)$
Introduction
On April 17th, before the US stock market opened, Abbott (NYSE: ABT) will hold a conference call to announce its financial results for the first quarter of 2024. As a global leader in healthcare, Abbott's performance has been steadily improving in recent years, especially benefiting from the COVID-19 pandemic. According to Bloomberg data, the follow...

103208831

Mar 28 08:38

$Abbott Laboratories(ABT.US)$ Hmmm. As usual, red again

Moomoo AI

Mar 6 10:54

Insiders selling shares with no recorded purchases over the last year could worry investors. Despite high insider ownership, recent selling activity suggests insiders don't see shares as a bargain.

Possible Bearish Signals With Abbott Laboratories Insiders Disposing Stock

Moomoo AI

Feb 6 13:10

The 4- and 5-star rated Dividend Aristocrats for 2024 include Abbott Laboratories, AbbVie Inc., Air Products & Chemicals, and others such as Coca-Cola Co., McDonald's Corp., Walmart Inc., and West Pharmaceuticals.

4- and 5-Star Rated "Dividend Aristocrat" Stocks for 2024 by CFRA

Moomoo AI

Jan 26 05:53

Analysts' outlook on Abbott Laboratories remains steady, despite projected slowdown in revenue growth to 4.6% annually until 2024, well below its historical 7.9% p.a. growth and slower than industry peers.

Earnings Update: Abbott Laboratories (NYSE:ABT) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts

Moomoo AI

Jan 24 13:58

Despite strong earnings per share growth, the market seems pessimistic about the company. Dividends paid have boosted total shareholder return, suggesting the company's performance remains strong even as share price gains slow.

Abbott Laboratories (NYSE:ABT) Shareholders Have Earned a 12% CAGR Over the Last Five Years

Luzi Ann Santos

Jan 24 09:58

Abbott shares slip as first-quarter earnings outlook misses estimates

$Abbott Laboratories(ABT.US)$ shares are falling after the healthcare products company issued first-quarter earnings guidance that fell short of market estimates.
Read more here: Abbott Shares Slip as First-Quarter Earnings Outlook Misses Estimates

Moomoo AI

Jan 24 07:16

Abbott is shifting focus from the dwindling COVID testing sector to its core segments, banking on products like continuous glucose monitors for future growth. The company also sees potential in the rising popularity of anti-obesity medications.

Abbott Labs' Fourth-quarter Sales Top Estimates Amid Strong Medical-device Demand

Movers and Shakers

Jan 24 07:13

ColumnsToday's Morning Movers and Top Ratings: NFLX, TSLA, ASML, DD and More

Morning Movers
Gapping up
$Netflix(NFLX.US)$ stock rose 9.4% after the streaming giant reported the addition of far more paying subscribers in the fourth quarter than expected, helped by a slate of popular programming.
$Tesla(TSLA.US)$ stock rose 1.3% after the EV manufacturer following a Reuters report which stated the company has informed suppliers it wants to start production of a new mass-market electric vehicle in mid-2025...

No comment yet